✓
Summary
2
Billing Details
3
Payment
Select License Type
Please fill your details and select preferred payment gateway.
Select Payment Method
You will be redirected to Razorpay secure payment gateway to complete your purchase.
Order Summary
Carcinoid Tumor Syndrome Management Market 2025-2035
The global Carcinoid Tumor Syndrome (CTS) management market is poised for robust growth, driven by the increasing prevalence of neuroendocrine tumors, advancements in diagnostic technologies, and innovative treatment options. Valued at USD 1,775.38 million in 2024, the market is projected to reach USD 5,993 million by 2034, reflecting a CAGR of 11.9% during the forecast period.
Report ID
25689
Domain Name
Healthcare
Format
PPT, PDF, WORD, EXCEL
Single User License:
$4,950
Total (inclusive of all taxes):
$4,950
Secure Payment By
We accept all major credit cards
